Apparent lability of neural tube closure in laboratory animals and humans.
Neural tube defects (NTDs), a set of structural abnormalities affecting the brain, spinal cord, and the skeletal and connective tissues that protect them, are common malformations among humans and laboratory animals. The embryogenesis of the neural tube is presented to convey the complexity of the phenomenon, the multiplicity of requisite cellular and subcellular processes, and the precise timing of events that must occur for successful neural tube development. Interruption, even transitory, of any of these intricate processes or disruption of an embryo's developmental schedule can lead to an NTD. The population distribution of human NTDs demonstrates that genetic predisposition functions in susceptibility to NTDs. Data from animal studies support these concepts. NTDs are common outcomes in developmental toxicity safety assessments, occurring among control and treated groups. Numerous agents have caused increased levels of NTDs in laboratory animals, and species with shorter gestational periods appear more prone to toxicant-induced NTDs than those with longer gestations. Data from post-implantation whole embryo culture, although not predictive of human risk, are useful in studying neurulation mechanisms and in demonstrating the importance of maintaining embryonic schedules of development. We conclude that the concept that NTDs are produced by only a few toxicants that selectively target the developing nervous system is untenable. Rather, the combination of the time in gestation that an agent is applied, its dose, and its ability to disrupt critical processes in neurulation leads to NTDs. We further conclude that, because of both the relatively high prevalence and the multifactorial nature of NTDs, the mere occurrence of an NTD is insufficient for inferring that the defect was caused by an exogenous agent.
DeSesso
J M
JM
Biomedical Research Institute, Mitretek Systems, McLean, Virginia 22102, USA. jdesesso@mitretek.org
Scialli
A R
AR
Holson
J F
JF
D000818:Animals; D001921:Brain / Q000166:cytology / Q000187:drug effects / Q000196:embryology; D002490:Central Nervous System / Q000166:cytology / Q000187:drug effects / Q000196:embryology*; D005314:Embryonic and Fetal Development / Q000187:drug effects; D020022:Genetic Predisposition to Disease; D005865:Gestational Age; D006801:Humans; D009432:Neural Crest / Q000166:cytology / Q000187:drug effects / Q000196:embryology; D009436:Neural Tube Defects / Q000139:chemically induced / Q000196:embryology* / Q000235:genetics; D009672:Notochord / Q000166:cytology / Q000187:drug effects / Q000196:embryology; D013723:Teratogens / Q000633:toxicity
D013723:Teratogens